Roberto Tirabosco
FOS Expression in Osteoid Osteoma and Osteoblastoma: A Valuable Ancillary Diagnostic Tool
Amary F, Baumhoer D, O'Donnell P, Pillay N, Lindsay D, Tirabosco R, Cool P, Gerrand C, Ye H, Berisha F, Markert E, Flanagan A. FOS Expression in Osteoid Osteoma and Osteoblastoma: A Valuable Ancillary Diagnostic Tool. Am J Surg Pathol 2019; 43:1661-1667.
Dec 1, 2019FOS Expression in Osteoid Osteoma and Osteoblastoma: A Valuable Ancillary Diagnostic Tool
Dec 1, 2019Am J Surg Pathol 2019; 43:1661-1667
Amary Fernanda, Baumhoer Daniel, O'Donnell Paul, Pillay Nischalan, Lindsay Daniel, Tirabosco Roberto, Cool Paul, Gerrand Craig, Ye Hongtao, Berisha Fitim, Markert Eva, Flanagan Adrienne M
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial
Seddon B, Dehbi H, Nash S, Forsyth S, Tirabosco R, Küver K, Jamieson D, Veal G, Marples M, Ali N, Benson C, Wood Z, Rothermundt C, Cowie F, Woll P, Leahy M, Whelan J, Strauss S, Beare S. Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial. Lancet Oncol 2017
Sep 4, 2017Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial
Sep 4, 2017Lancet Oncol 2017
Seddon Beatrice, Dehbi Hakim-Moulay, Nash Stephen, Forsyth Sharon, Tirabosco Roberto, Küver Katja, Jamieson David, Veal Gareth J, Marples Maria, Ali Nasim, Benson Charlotte, Wood Zoe, Rothermundt Christian, Cowie Fiona, Woll Penella J, Leahy Michael, Whelan Jeremy, Strauss Sandra J, Beare Sandy